"Atlantic Health System, headquartered in Morristown, New Jersey has a long-standing tradition of providing exceptional patient outcomes and experiences. Atlantic Health System includes Morristown Medical Center in Morristown, NJ; Overlook Medical Center in Summit, NJ; Newton Medical Center in Newton, NJ; Chilton Medical Center in Pompton Plains, NJ; Hackettstown Medical Center in Hackettstown, NJ; and Goryeb Children’s Hospital in Morristown, NJ, as well as Atlantic Rehabilitation, and Atlantic Visiting Nurse. In addition, we have more than 1,000 doctors, nurse practitioners and physician assistants affiliated with us through Atlantic Medical Group."

During the past decade, Atlantic Health System conducted 39 clinical trials. In the 10-year time frame, 39 clinical trials started and 12 clinical trials were completed, i.e. on average, 30.8% percent of trials that started reached the finish line to date. In the past 5 years, 19 clinical trials started and 8 clinical trials were completed. i.e. 42.1% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Atlantic Health System" #1 sponsor was "Atlantic Health System" with 7 trials, followed by "Bristol-Myers Squibb" with 3 trials sponsored, "BioMarin Pharmaceutical" with 2 trials sponsored, "Cornerstone Pharmaceuticals" with 2 trials sponsored and "Edwards Lifesciences" with 2 trials sponsored. Other sponsors include 33 different institutions and companies that sponsored additional 39 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Atlantic Health System" #1 collaborator was "Translational Drug Development" with 2 trials as a collaborator, "Amgen" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "EMD Serono" with 1 trials as a collaborator and "Eisai Inc." with 1 trials as a collaborator. Other collaborators include 9 different institutions and companies that were collaborators in the rest 19 trials.

According to Clinical.Site data, the most researched conditions in "Atlantic Health System" are "Pelvic Organ Prolapse" (5 trials), "Melanoma" (3 trials), "Renal Cell Carcinoma" (3 trials), "Aortic Valve Stenosis" (2 trials) and "Bladder Cancer" (2 trials). Many other conditions were trialed in "Atlantic Health System" in a lesser frequency.

Most popular intervention types in "Atlantic Health System" are "Drug" (30 trials), "Device" (8 trials), "Biological" (7 trials), "Other" (6 trials) and "Procedure" (5 trials). Other intervention types were less common.

The name of intervention was led by "Nivolumab" (4 trials), "Gemcitabine" (3 trials), "Carboplatin" (2 trials), "Cisplatin" (2 trials) and "Leucovorin" (2 trials). Other intervention names were less common.

The vast majority of trials in "Atlantic Health System" are 38 trials for "All" genders, 15 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Atlantic Health System". undefined are not yet recruiting, 16 are recruiting, 11 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 17 completed trials in Atlantic Health System, undefined suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Atlantic Health System, 10 "Phase 1" clinical trials were conducted, 13 "Phase 2" clinical trials and 10 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 4 trials, and there were also 6 trials that are defined as “Not Applicable".